T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTCF
2526
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $235K | ﹤0.01% |
37,297
+14,360
| +63% | +$115K |
|
2527
Natural Gas Services Group
NGS
$474M
| $233K | ﹤0.01% |
21,188
| – | – |
|
|
SWI
2528
DELISTED
SolarWinds Corporation Common Stock
SWI
| $233K | ﹤0.01% |
22,757
+2,576
| +13% | +$30.6K |
|
2529
Vaalco Energy
EGY
$592M
| $232K | ﹤0.01% |
33,377
-7,923
| -19% | -$56.7K |
|
2530
First US Bancshares
FUSB
$90.7M
| $230K | ﹤0.01% |
20,950
| – | – |
|
2531
Hims & Hers Health
HIMS
$6.71B
| $230K | ﹤0.01% |
50,681
+11,581
| +30% | +$49.4K |
|
|
WW
2532
DELISTED
WW International
WW
| $230K | ﹤0.01% |
36,063
+6,182
| +21% | +$52K |
|
|
BASE
2533
DELISTED
Couchbase
BASE
| $229K | ﹤0.01% |
13,924
-6,435
| -32% | -$102K |
|
2534
Blink Charging
BLNK
$87.1M
| $229K | ﹤0.01% |
13,877
+2,181
| +19% | +$40.9K |
|
2535
Gildan
GIL
$10.6B
| $229K | ﹤0.01% |
7,989
-32
| -0.4% | -$1.02K |
|
|
VTLE
2536
DELISTED
Vital Energy
VTLE
| $229K | ﹤0.01% |
+3,328
| New | +$267K |
|
|
CSII
2537
DELISTED
Cardiovascular Systems, Inc.
CSII
| $229K | ﹤0.01% |
15,957
+373
| +2% | +$6.47K |
|
2538
Rimini Street
RMNI
$470M
| $228K | ﹤0.01% |
37,918
+469
| +1% | +$2.79K |
|
|
TUP
2539
DELISTED
Tupperware Brands Corporation
TUP
| $227K | ﹤0.01% |
35,864
-8,405
| -19% | -$93.8K |
|
2540
Sturm, Ruger & Co
RGR
$601M
| $226K | ﹤0.01% |
3,552
+173
| +5% | +$11.6K |
|
|
CHS
2541
DELISTED
Chicos FAS, Inc.
CHS
| $226K | ﹤0.01% |
45,526
-2,932
| -6% | -$14.8K |
|
2542
Distribution Solutions Group
DSGR
$1.61B
| $225K | ﹤0.01% |
+8,744
| New | +$182K |
|
2543
Western New England Bancorp
WNEB
$282M
| $225K | ﹤0.01% |
30,100
| – | – |
|
2544
AnaptysBio
ANAB
$1.66B
| $223K | ﹤0.01% |
10,983
+111
| +1% | +$2.46K |
|
2545
Comtech Telecommunications
CMTL
$52.7M
| $223K | ﹤0.01% |
24,631
+200
| +0.8% | +$2.5K |
|
2546
Hertz
HTZ
$838M
| $223K | ﹤0.01% |
+14,085
| New | +$278K |
|
2547
Community Health Systems
CYH
$419M
| $222K | ﹤0.01% |
59,291
+5,438
| +10% | +$38.3K |
|
2548
Inovio Pharmaceuticals
INO
$93M
| $222K | ﹤0.01% |
10,707
+240
| +2% | +$6.76K |
|
2549
Phibro Animal Health
PAHC
$1.38B
| $222K | ﹤0.01% |
11,594
+200
| +2% | +$3.79K |
|
2550
PMV Pharmaceuticals
PMVP
$65.1M
| $222K | ﹤0.01% |
15,613
+1,109
| +8% | +$16.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.